课题基金 / 基金详情

MICROSPORIDIOSIS IN PATIENTS WITH HIV INFECTION

MICROSPORIDIOSIS IN PATIENTS WITH HIV INFECTION
HIV 感染患者的微孢子虫病
批准号：
5218015
负责人：
ROSEMARY SOAVE
金额：
$0.0万
依托单位：
--
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/5218015
关键词：
AIDS therapy HIV infections Microsporidia benzimidazoles clinical research clinical trials diagnosis design /evaluation human subject noninvasive diagnosis opportunistic infections parasitic disease chemotherapy parasitic disease diagnosis protozoal infection

项目摘要

项目成果

ROSEMARY SOAVE的其他基金

相似基金

相关文献

中文摘要
翻译
本项目是一个由治疗和诊断三部分组成的研究
英文摘要
This project is a three part study of therapy for and diagnosis of microsporidiosis in patients with AIDS. Part A is a double-blind, placebo-controlled, multicenter study of albendazole for microsporidiosis. Part B is a compassionate use, open label study of albendazole that will enable us to treat patients who cannot be enrolled in Part A. Part C is a study of invasive and noninvasive techniques for the diagnosis of microsporidiosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IMMUNOPATHOGENESIS OF CRYPTOSPORIDIOSIS
SAFETY & EFFICACY OF CLARITHROMYCIN FOR AIDS-RELATED CRYPTOSPORIDIAL DIARRHEA
PHASE I/II OPEN LABEL EVALUATION OF NITAZOXANIDE CRYPTOSPORIDIOSIS IN AIDS
IMMUNOPATHOGENESIS OF CRYPTOSPORIDIOSIS
海外基金